What Researchers Did
Researchers retrospectively analyzed data from 297 carbon monoxide-poisoned patients who received hyperbaric oxygen therapy over a ten-year period to identify the type, incidence, and timing of complications.
What They Found
The study found a 6% mortality rate, with 8% of patients experiencing cardiac arrest and 3% having respiratory arrest or myocardial infarction, all occurring prior to hyperbaric oxygen therapy. During hyperbaric oxygen therapy, complications included emesis (6%), seizures (5%), agitation (2%), cardiac dysrhythmias or arrests (2%), and arterial hypotension (2%), with tension pneumothorax noted as the most significant HBOT-attributable complication.
What This Means for Canadian Patients
Canadian patients receiving hyperbaric oxygen therapy for carbon monoxide poisoning should be closely monitored for potential complications such as emesis, seizures, and cardiac events. Understanding these risks can help healthcare providers anticipate and manage adverse events, improving patient safety during treatment.
Canadian Relevance
This study was not conducted in Canada and does not have a direct Canadian connection.
Study Limitations
As a retrospective study, it relies on existing medical records, which may introduce limitations such as incomplete data or potential for selection bias.